80 related articles for article (PubMed ID: 11273797)
1. Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study.
Allegra L; Blasi F; de Bernardi B; Cosentini R; Tarsia P
Pulm Pharmacol Ther; 2001; 14(2):149-55. PubMed ID: 11273797
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation and symptomatic treatment of surinfectious exacerbations of COPD: preliminary study of antibiotic treatment combined with fenspiride (Pneumorel 80mg) versus placebo].
Lirsac B; Benezet O; Dansin E; Nouvet G; Stach B; Voisin C
Rev Pneumol Clin; 2000 Feb; 56(1):17-24. PubMed ID: 10740110
[TBL] [Abstract][Full Text] [Related]
3. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease.
Llor C; Moragas A; Hernández S; Bayona C; Miravitlles M
Am J Respir Crit Care Med; 2012 Oct; 186(8):716-23. PubMed ID: 22923662
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
Beier J; Chanez P; Martinot JB; Schreurs AJ; Tkácová R; Bao W; Jack D; Higgins M
Pulm Pharmacol Ther; 2007; 20(6):740-9. PubMed ID: 17088091
[TBL] [Abstract][Full Text] [Related]
6. [Antibiotic treatment for acute episodes of chronic obstructive pulmonary disease].
Alonso Martínez JL; Rubio Obanos MT; Sampériz Legarre AL; Escolar Castellón F; Carrasco del Amo ME
An Med Interna; 1992 Aug; 9(8):377-80. PubMed ID: 1391559
[TBL] [Abstract][Full Text] [Related]
7. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
8. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
Hauke W; Köhler G; Henneicke-Von Zepelin HH; Freudenstein J
Chemotherapy; 2002 Dec; 48(5):259-66. PubMed ID: 12476043
[TBL] [Abstract][Full Text] [Related]
9. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
10. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
11. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
Niewoehner DE; Erbland ML; Deupree RH; Collins D; Gross NJ; Light RW; Anderson P; Morgan NA
N Engl J Med; 1999 Jun; 340(25):1941-7. PubMed ID: 10379017
[TBL] [Abstract][Full Text] [Related]
12. Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.
Martinez FJ; Boscia J; Feldman G; Scott-Wilson C; Kilbride S; Fabbri L; Crim C; Calverley PM
Respir Med; 2013 Apr; 107(4):550-9. PubMed ID: 23332861
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
14. Acute exacerbation of COPD: factors associated with poor treatment outcome.
Dewan NA; Rafique S; Kanwar B; Satpathy H; Ryschon K; Tillotson GS; Niederman MS
Chest; 2000 Mar; 117(3):662-71. PubMed ID: 10712989
[TBL] [Abstract][Full Text] [Related]
15. Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Grossman RF; Ambrusz ME; Fisher AC; Khashab MM; Kahn JB
Clin Ther; 2006 Aug; 28(8):1175-1180. PubMed ID: 16982294
[TBL] [Abstract][Full Text] [Related]
16. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
18. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
Kahn JB; Khashab M; Ambruzs M
Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
[TBL] [Abstract][Full Text] [Related]
19. Indacaterol therapy in patients with COPD not receiving other maintenance treatment.
Decramer M; Rossi A; Lawrence D; McBryan D
Respir Med; 2012 Dec; 106(12):1706-14. PubMed ID: 23031496
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.
Meister R; Wittig T; Beuscher N; de Mey C
Arzneimittelforschung; 1999 Apr; 49(4):351-8. PubMed ID: 10337455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
